George E Withers, Iii

Introduction

George E Withers, III is an esteemed inventor based in Livermore, California. He has made significant contributions to the field of cholesterol measurement, with a focus on developing innovative assay devices and methods that facilitate accurate and efficient analysis of low-density lipoprotein (LDL) cholesterol levels.

Latest Patents

With a total of two patents to his name, George has made noteworthy advancements in health diagnostics. His latest patents include:

1. **Device and Method for Measuring LDL-Associated Cholesterol**: This patent describes an assay device and method designed to determine the concentration of LDL-associated cholesterol (LDL-C) in body-fluid samples, such as blood samples. This innovation allows for more precise testing of cholesterol levels, which is crucial in managing cardiovascular health.

2. **Assay Device for Direct Measurement of LDL Cholesterol**: This invention outlines a method that utilizes selective precipitation of very low-density lipoproteins (VLDL) and chylomicrons, along with immunoseparation of high-density lipoprotein (HDL) from a blood fluid sample. The unique design of the assay device enables the entire testing procedure to be conducted in a flow strip format, enhancing convenience and efficiency in cholesterol testing.

Career Highlights

George is currently associated with Cholestech Corporation, where he applies his expertise to the development of innovative health diagnostic devices. His work has been pivotal in advancing technologies that are critical for effective health management and disease prevention.

Collaborations

Throughout his career, George has collaborated with talented colleagues, including Shireen S Khan and Suyue Qian. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and innovations, further enhancing the development of pioneering health technologies.

Conclusion

George E Withers, III exemplifies the spirit of innovation within the health diagnostics field. His contributions through patented inventions have significantly improved the methodologies for measuring LDL cholesterol, ultimately benefiting public health. His ongoing work at Cholestech Corporation, along with collaborative efforts with fellow innovators, continues to pave the way for future advancements in medical testing and diagnostics.